We will find out how much anticoagulant nonadherence causes strokes and deaths in people with Afib, how the timing of missed doses matters, and which patients are harmed the most. For example, are certain types of people (e.g. by sex and gender, income levels, rural/urban residence, age category, race/ethnicity) harmed more than others? Then we will build our results into an online risk calculator for patients and clinicians.

After you express interest, our team will contact you to learn about your interest, confirm eligibility, share further study details, and outline next steps. Patient partners' roles depend on their skills and interests. Their primary role is to help with interpreting and communicating the study findings by recommending ways and places to share the results, helping us write information for patient groups, and helping us develop reports of the results that are easily understood by the public. For those who are interested, we would also appreciate input from patient partners on how to make our analyses (and therefore our results) more relevant to the interests of people living with Afib.